Ji-Hyeon Hwang

Dr. Ji-Hyeon Hwang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
JHJi-Hyeon Hwang
Ji-Hyeon Hwang
GLGyeongmin Lee
Gyeongmin Lee
NKN/A Kim
N/A Kim
JPJong-Hyeon Park
Jong-Hyeon Park
Min Ja LeeMin Ja Lee
Min Ja Lee
SKSu-mi Kim
Su-mi Kim
There are seven viral serotypes of foot-and-mouth disease virus (FMDV): A, O, C, Asia 1, and Southern African Territories 1, 2, and 3 (SAT 1–3). Unlike serotype O FMDV vaccine strains, vaccine strains of serotype A FMDV do not provide broad-range cross-reactivity in serological matching tests with field isolates. Therefore, the topotype/lineage vaccine strain circulating in many countries and a highly immunogenic strain might be advantageous to control serotype A FMDV. We developed a new vaccine strain, A/SKR/Yeoncheon/2017 (A-1), which belongs to the A/ASIA/Sea-97 lineage that frequently occurs in Asian countries. Using virus plaque purification, we selected a vaccine virus with high antigen productivity and the lowest numbers of P1 mutations among cell-adapted virus populations. The A/SKR/Yeoncheon/2017 (A-1) vaccine strain has a single amino acid mutation, VP2 E82K, in the P1 region, and it is perfectly adapted to suspension culture. The A/SKR/Yeoncheon/2017 (A-1) experimental vaccine conferred high immunogenicity in pigs. The vaccine strain was serologically matched with various field isolates in two-dimensional virus neutralization tests using bovine serum. Vaccinated mice were protected against an A/MAY/97 virus that was serologically mismatched with the vaccine strain. Thus, A/SKR/Yeoncheon/2017 (A-1) might be a promising vaccine candidate for protection against the emerging FMDV serotype A in Asia.

1 January 2019 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
JHJi-Hyeon Hwang
Ji-Hyeon Hwang
KLKwang-Nyeong Lee
Kwang-Nyeong Lee
SKSu-mi Kim
Su-mi Kim
GLGyeongmin Lee
Gyeongmin Lee
YMYoonjung Moon
Yoonjung Moon
JPJong-Hyeon Park
Jong-Hyeon Park
Hwang JH, et al. J Vet Sci. 2019 May;20(3):e29. https://doi.org/10.4142/jvs.2019.20.e29

1 January 2015 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
RKRae-Hyung Kim
Rae-Hyung Kim
JCJia-Qi Chu
Jia-Qi Chu
JPJeong-Nam Park
Jeong-Nam Park
SLSeo-Yong Lee
Seo-Yong Lee
YLYeo-Joo Lee
Yeo-Joo Lee
JPJong-Hyeon Park
Jong-Hyeon Park
Kim RH, et al. Clin Exp Vaccine Res. 2015 Jan;4(1):114-118. https://doi.org/10.7774/cevr.2015.4.1.114

26 August 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
JHJi-Hyeon Hwang
Ji-Hyeon Hwang
KLKwang-Nyeong Lee
Kwang-Nyeong Lee
SKSu-mi Kim
Su-mi Kim
HKHyejin Kim
Hyejin Kim
SPSung-Han Park
Sung-Han Park
JPJong-Hyeon Park
Jong-Hyeon Park
In South Korea, a mandatory nation-wide foot-and-mouth disease (FMD) vaccination policy is in place. However, a major side effect of the current method of intramuscular (IM) administration of oil-adjuvanted FMD vaccines is the formation of granulomas in the muscles of pigs. To address this issue, we assessed the possible application of intradermal (ID) vaccination. Initially, we compared the serological immune response in specific pathogen-free pigs inoculated with FMD vaccines formulated with eight different adjuvants, administered twice at the neck site using a syringe with a needle via the ID route. Among the formulations (water-in-oil-in-water (W/O/W), oil-in-water (O/W), and polymer nanomaterials), ISA 207 of W/O/W was the most effective in inducing immunogenicity followed by ISA 201 of W/O/W. ISA 207 was further tested in formulations of different antigen doses (12 or 1.2 μg) delivered via both IM and ID routes. All four treatments successfully protected the pigs against FMD virus challenges. To assess the feasibility of the field application of the vaccines with ISA 207, we conducted ID vaccination of conventional pigs using a needle-free device, resulting in the detection of significant levels of neutralizing antibodies. ISA 207 was shown to be superior to ISA 201 in inducing immunogenicity via the ID route. In conclusion, ISA 207 could be a suitable adjuvant for ID vaccination in terms of vaccine efficacy for FMD, allowing for alternate use of ID vaccination and subsequent reduction in the incidences of granuloma formation in the field.

10 September 2020 in Viruses
Verified
Journal Article
Open access
PDF file
GLGyeongmin Lee
Gyeongmin Lee
JHJi-Hyeon Hwang
Ji-Hyeon Hwang
AKAro Kim
Aro Kim
JPJong-Hyeon Park
Jong-Hyeon Park
Min Ja LeeMin Ja Lee
Min Ja Lee
SKSu-mi Kim
Su-mi Kim
Foot-and-mouth disease (FMD) is an economically devastating animal disease. Adapting the field virus to cells is critical to the vaccine production of FMD viruses (FMDV), and heparan sulfate (HS) and Jumonji C-domain-containing protein 6 (JMJD6) are alternative receptors of cell-adapted FMDV. We performed serial passages of FMDV O/SKR/Andong/2010, classified as the O/Mya-98 topotype/lineage and known as a highly virulent strain, to develop a vaccine seed virus. We traced changes in the amino acid sequences of the P1 region, plaque phenotypes, and the receptor usage of the viruses, and then structurally analyzed the mutations. VP3 H56R and D60G mutations were observed in viruses using the HS receptor and led to changes in the hydrogen bonding between VP3 56 and 60. A VP1 P208L mutation was observed in the virus using the JMJD6 receptor during cell adaptation, enabling the interaction with JMJD6 through the formation of a new hydrogen bond with JMJD6 residue 300. Furthermore, VP1 208 was near the VP1 95/96 amino acids, previously reported as critical mutations for JMJD6 receptor interactions. Thus, the mutation at VP1 208 could be critical for cell adaptation related to the JMJD6 receptor and may serve as a basis for mechanism studies on FMDV cell adaptation.

21 June 2024 in Viruses
Verified
Journal Article
Open access
PDF file
GCGiyoun Cho
Giyoun Cho
HKHyejin Kim
Hyejin Kim
DKDong-Wan Kim
Dong-Wan Kim
SHSeong Yun Hwang
Seong Yun Hwang
JHJi-Hyeon Hwang
Ji-Hyeon Hwang
JPJong-Hyeon Park
Jong-Hyeon Park
Foot-and-mouth disease virus (FMDV) is a highly contagious virus that affects cloven-hoofed animals and causes severe economic losses in the livestock industry. Given that this high-risk pathogen has to be handled in a biosafety level (BSL)-3 facility for safety reasons and the limited availability of BSL-3 laboratories, experiments on FMDV call for more attention. Therefore, we aimed to develop an FMDV experimental model that can be handled in BSL-2 laboratories. The NanoBiT luciferase (Nano-luc) assay is a well-known assay for studying protein–protein interactions. To apply the NanoBiT split luciferase assay to the diagnosis and evaluation of FMD, we developed an inactivated HiBiT-tagged Asia1 Shamir FMDV (AS-HiBiT), a recombinant Asia1 shamir FMDV with HiBiT attached to the VP1 region of Asia1 shamir FMDV. In addition, we established LgBiT-expressing LF-BK cell lines, termed LgBit-LF-BK cells. It was confirmed that inactivated AS-HiBiT infected LgBiT-LF-BK cells and produced a luminescence signal by binding to the intracellular LgBiT of LgBiT-LF-BK cells. In addition, the luminescence signal became stronger as the number of LgBiT-LF-BK cells increased or the concentration of inactivated AS-HiBiT increased. Moreover, we confirmed that inactivated AS-HiBiT can detect seroconversion in sera positive for FMDV-neutralizing antibodies. This NanoBiT split luciferase assay system can be used for the diagnosis and evaluation of FMD and expanded to FMD-like virus models to facilitate the evaluation of FMDV vaccines and antibodies.